213 related articles for article (PubMed ID: 35975633)
21. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
22. Association Between Glucosamine Use and the Risk of Incident Heart Failure: The UK Biobank Cohort Study and Mendelian Randomization Analysis.
Zheng J; Hukportie DN; Zhang Y; Huang J; Ni C; Lip GYH; Tang S
Mayo Clin Proc; 2023 Aug; 98(8):1177-1191. PubMed ID: 37422736
[TBL] [Abstract][Full Text] [Related]
23. Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999-2020.
Cho S; Park WJ
Investig Clin Urol; 2024 Jan; 65(1):23-31. PubMed ID: 38197748
[TBL] [Abstract][Full Text] [Related]
24. Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran.
Basiri A; Shakhssalim N; Jalaly NY; Miri HH; Partovipour E; Panahi MH
Asian Pac J Cancer Prev; 2014; 15(3):1459-63. PubMed ID: 24606483
[TBL] [Abstract][Full Text] [Related]
25. Trends in the age of hospitalized patients with urological cancers: A 17-year experience.
Ishii N; Hatakeyama S; Miura H; Tanaka R; Oishi T; Horiguchi H; Hosogoe S; Fujita N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
Int J Urol; 2023 Jul; 30(7):572-578. PubMed ID: 36941076
[TBL] [Abstract][Full Text] [Related]
26. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
27. Nongenetic Factors Associated With Psychotic Experiences Among UK Biobank Participants: Exposome-Wide Analysis and Mendelian Randomization Analysis.
Lin BD; Pries LK; Sarac HS; van Os J; Rutten BPF; Luykx J; Guloksuz S
JAMA Psychiatry; 2022 Sep; 79(9):857-868. PubMed ID: 35857297
[TBL] [Abstract][Full Text] [Related]
28. Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies.
Hou L; Li H; Si S; Yu Y; Sun X; Liu X; Yan R; Yu Y; Wang C; Yang F; Wang Q; Xue F
Atherosclerosis; 2021 Mar; 320():112-121. PubMed ID: 33485635
[TBL] [Abstract][Full Text] [Related]
29. Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional Group.
Cancrini F; Osman N; Doizi S; Guillot-Tantay C; Hüsch T; Illiano E; Tutolo M; Tienza A; Culha MG; Vale L; Raison N; Herve F; Grande P; Roupret M; Phé V
Minerva Urol Nephrol; 2023 Apr; 75(2):163-171. PubMed ID: 36999836
[TBL] [Abstract][Full Text] [Related]
30. [Incidence and mortality of urological cancers in 2012 in France].
Rébillard X; Grosclaude P; Leone N; Velten M; Coureau G; Villers A; Irani J; Lebret T; Rigaud J; Pfister C; Patard JJ; Richaud P; Salomon L; Coloby P; Soulié M;
Prog Urol; 2013 Nov; 23 Suppl 2():S57-65. PubMed ID: 24485294
[TBL] [Abstract][Full Text] [Related]
31. Insight into the causality between basal metabolic rate and endometrial and ovarian cancers: Analysis utilizing systematic Mendelian randomization and genetic association data from over 331,000 UK biobank participants.
Zhang H; Qiu J; Meng F; Shu X
Eur J Clin Invest; 2023 Jun; 53(6):e13971. PubMed ID: 36807123
[TBL] [Abstract][Full Text] [Related]
32. Iron Status and Cancer Risk in UK Biobank: A Two-Sample Mendelian Randomization Study.
Yuan S; Carter P; Vithayathil M; Kar S; Giovannucci E; Mason AM; Burgess S; Larsson SC
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32092884
[TBL] [Abstract][Full Text] [Related]
33. Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects.
Song Y; Hu J; Chen Q; Guo J; Zou Y; Zhang W; Chen X; Hu W; Huang P
Gene; 2018 Dec; 679():241-252. PubMed ID: 30195633
[TBL] [Abstract][Full Text] [Related]
34. Causal Association between Chronic Kidney Disease and Risk of 19 Site-Specific Cancers: A Mendelian Randomization Study.
Tang L; Li C; Chen W; Zeng Y; Yang H; Hu Y; Song H; Zeng X; Li Q; Fu P
Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1233-1242. PubMed ID: 35333923
[TBL] [Abstract][Full Text] [Related]
35. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
36. Milk consumption and risk of twelve cancers: A large-scale observational and Mendelian randomisation study.
Lumsden AL; Mulugeta A; Hyppönen E
Clin Nutr; 2023 Jan; 42(1):1-8. PubMed ID: 36473423
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Glycated Hemoglobin (HbA
Au Yeung SL; Luo S; Schooling CM
Diabetes Care; 2018 Sep; 41(9):1991-1997. PubMed ID: 29950300
[TBL] [Abstract][Full Text] [Related]
38. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
39. Blood Pressure and Risk of Cardiovascular Disease in UK Biobank: A Mendelian Randomization Study.
Wan EYF; Fung WT; Schooling CM; Au Yeung SL; Kwok MK; Yu EYT; Wang Y; Chan EWY; Wong ICK; Lam CLK
Hypertension; 2021 Feb; 77(2):367-375. PubMed ID: 33390054
[TBL] [Abstract][Full Text] [Related]
40. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
Bourgade V; Drouin SJ; Yates DR; Parra J; Bitker MO; Cussenot O; Rouprêt M
World J Urol; 2014 Apr; 32(2):475-9. PubMed ID: 23455886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
